Skip to main content

Only One in Four Doctors Very Satisfied With Electronic Health Record System

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 1, 2024.

via HealthDay

FRIDAY, Aug. 30, 2024 -- Only one-fourth of family physicians report being very satisfied with their electronic health record (EHR), according to a study published online Aug. 29 in JAMA Network Open.

A. Jay Holmgren, Ph.D., from the University of California, San Francisco, and colleagues measured family physician satisfaction with their EHR, EHR usability, and the association of EHR usability with satisfaction and burnout. The analysis included survey responses from 2,067 family physicians seeking American Board of Family Medicine recertification in 2022.

The researchers found that 27.2 percent were very satisfied, 37.5 percent were somewhat satisfied, 16.7 percent were somewhat dissatisfied, and 9.6 percent were very dissatisfied with their EHR. The highest usability was seen for readability of information, with 26.3 percent of respondents rating it as excellent. Usefulness of alerts had the lowest usability, with 12.7 percent of respondents rating it as excellent. Good or excellent usability for entering data (β = 0.09), alignment with workflow processes (β = 0.11), ease of finding information (β = 0.14), and usefulness of alerts (β = 0.11) were associated with physicians being very satisfied with their EHR, and being very satisfied with the EHR was associated with reduced frequency of burnout (β = −0.64).

"One-fourth reported being somewhat or very dissatisfied, a concerning finding amplified by the inverse association between EHR satisfaction and burnout," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Study Compares Benefits, Harms of Treatments for Chronic Hives

WEDNESDAY, July 23, 2025 -- Omalizumab and remibrutinib may be the most effective treatments for reducing hives, itch, and swelling with chronic urticaria, according to a study...

USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk

WEDNESDAY, July 23, 2025 -- Moderate U.S. Preventive Services Task Force (USPSTF) preeclampsia risk factors have little value for estimating the risk for preeclampsia, according...

Endocrine Society, July 12-15

The annual meeting of the Endocrine Society (ENDO 2025) was held from July 12 to 15 in San Francisco, attracting more than 7,000 participants, including clinicians, academicians...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.